Researchers at the University of Pennsylvania compared GLP-1 medications with other antidiabetic medications and found that GLP-1 drug use was associated with a higher overall risk of alopecia over an average follow-up of 2.7 years in the study, published Wednesday, July 22 in The BMJ
Caution is advised in patients with a history of pancreatitis, severe gastroparesis, or diabetic retinopathy
Food and Drug Administration doesnt require testing of supplements before they can be sold, so third-party testing offers a way to ensure quality
If you have commercial insurance, the Mounjaro savings card can cut your monthly cost to $25 per month
95% confidence interval [CI], 0.68 to 0.95
An oral tirzepatide with unpredictable bioavailability would be a scientific gamble with no guaranteed payoff